SCHEMBL25150910

SCHEMBL25150910

COc1cc(Br)cc2c1C(=O)N(C1CCN(C(=O)OC(C)(C)C)C1)CC2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP30 Q70CQ3 3/20 0.42
PDE4B Q07343 1/20 0.41
FPR2 P25090 3/20 0.41
TP53 P04637 1/20 0.39
KDM4E B2RXH2 1/20 0.39
MAPT P10636 1/20 0.39
THRB P10828 1/20 0.39
GPR119 Q8TDV5 2/20 0.39
PIK3CA P42336 1/20 0.38
TNF P01375 2/20 0.38
LITAF Q99732 2/20 0.38
CCNT1 O60563 1/20 0.38
CDK9 P50750 1/20 0.38
STS P08842 1/20 0.38
IDO1 P14902 1/20 0.37
TDO2 P48775 1/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
NR1H2 P55055 1/20 0.37
MEN1 O00255 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30400063 1.00 USP30 (0.42) USP30PDE4BFPR2TP53KDM4E
SCHEMBL21593334 0.80 SIK1 (0.42) KDM4EMAPTMEN1KMT2A
SCHEMBL29693114 0.78 USP30 (0.38) USP30PDE4BFPR2TP53STS
SCHEMBL24558077 0.78 USP30 (0.38) USP30PDE4BFPR2TP53STS
SCHEMBL20134975 0.78 PIK3CA (0.46) USP30FPR2KDM4EMAPTTHRB
SCHEMBL4106892 0.78 FPR2 (0.46) USP30FPR2KDM4EMAPTTHRB
SCHEMBL8230370 0.77 HRH3 (0.49) USP30TP53GPR119PIK3CASTS
SCHEMBL30398870 0.75 PIK3CA (0.37) USP30GPR119PIK3CATNFLITAF
SCHEMBL23761149 0.74 PIK3CA (0.44) USP30FPR2TP53KDM4EMAPT
SCHEMBL26506272 0.74 PIK3CA (0.44) USP30FPR2TP53KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023064880-A1 COMPOUNDS AND METHODS FOR MODULATING NUCLEIC ACID SPLICING REMIX THERAPEUTICS INC. (US) 2023-04-20 WO disclosed